ARTICLE | Company News
Cellectis, Johns Hopkins University, Sangamo BioSciences Inc functional genomics news
June 20, 2005 7:00 AM UTC
Cellectis said the European Patent Office's Opposition Division revoked the university's European Patent No. EP 0682699 covering targeted recombination and gene correction. Cellectis said that SGMO wa...